Combined Transcriptomics and Chemical-Genetics Reveal Molecular Mode of Action of Valproic acid, an Anticancer Molecule using Budding Yeast Model

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Golla, Upendarrao ^a   Joseph, Deepthi ^a   Tomar, Raghuvir Singh ^a  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH BHOPAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LIPID; SACCHAROMYCES CEREVISIAE PROTEIN; SML1 PROTEIN, S CEREVISIAE; TRANSCRIPTOME; VALPROIC ACID;

BIOLOGICAL MODEL; CELL WALL; CHEMISTRY; DNA REPAIR; DRUG EFFECT; GENOME-WIDE ASSOCIATION STUDY; HOMEOSTASIS; MAPK SIGNALING; METABOLISM; MITOCHONDRION; OSMOSIS; OSMOTIC PRESSURE; OXIDATIVE STRESS; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CELL WALL; DNA REPAIR; GENOME-WIDE ASSOCIATION STUDY; HOMEOSTASIS; LIPIDS; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIA; MODELS, GENETIC; OSMOSIS; OSMOTIC PRESSURE; OXIDATIVE STRESS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTOME; VALPROIC ACID;

EID: 84991467009     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep35322     Document Type: Article

References (59)

1. Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41-45, doi: 10.1038/47412 (2000).
2. Mandal, P. et al. In Molecular mechanisms and physiology of disease: Implications for Epigenetics and Health (eds Nilanjana, Maulik & Tom, Karagiannis) 113-126 (Springer New York, 2014).
3. de Nadal, E., Ammerer, G. & Posas, F. Controlling gene expression in response to stress. Nat Rev Genet 12, 833-845, doi: 10.1038/ nrg3055 (2011).
4. Nebbioso, A., Carafa, V., Benedetti, R. & Altucci, L. Trials with 'epigenetic' drugs: An update. Molecular Oncology 6, 657-682, doi: 10.1016/j.molonc.2012.09.004 (2012).
5. Dokmanovic, M., Clarke, C. & Marks, P. A. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 5, 981-989, doi: 10.1158/1541-7786.MCR-07-0324 (2007).
6. Chateauvieux, S., Morceau, F., Dicato, M. & Diederich, M. Molecular and Therapeutic Potential and Toxicity of Valproic Acid. Journal of Biomedicine and Biotechnology, doi: Artn 479364 10.1155/2010/479364 (2010).
7. Mori, H., Takahashi, K. & Mizutani, T. Interaction between valproic acid and carbapenem antibiotics. Drug Metabolism Reviews 39, 647-657, doi: 10.1080/03602530701690341 (2007).
8. Hrebackova, J., Hrabeta, J. & Eckschlager, T. Valproic acid in the complex therapy of malignant tumors. Curr Drug Targets 11, 361-379 (2010).
9. Phiel, C. J. et al. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. Journal of Biological Chemistry 276, 36734-36741, doi: 10.1074/jbc.M101287200 (2001).
10. Chen, G., Huang, L. D., Jiang, Y. M. & Manji, H. K. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 72, 1327-1330 (1999).
11. Botstein, D. & Fink, G. R. Yeast: an experimental organism for 21st Century biology. Genetics 189, 695-704, doi: 10.1534/ genetics.111.130765 (2011).
12. Gerhold, D. L., Jensen, R. V. & Gullans, S. R. Better therapeutics through microarrays. Nat Genet 32, 547-552, doi: 10.1038/ng1042 (2002).
13. Outten, C. E. & Albetel, A. N. Iron sensing and regulation in Saccharomyces cerevisiae: Ironing out the mechanistic details. Curr Opin Microbiol 16, 662-668, doi: 10.1016/j.mib.2013.07.020 (2013).
14. Atamna, H., Walter, P. B. & Ames, B. N. The role of heme and iron-sulfur clusters in mitochondrial biogenesis, maintenance, and decay with age. Arch Biochem Biophys 397, 345-353, doi: 10.1006/abbi.2001.2671 (2002).
15. Chan, E. Y. & McQuibban, G. A. Phosphatidylserine decarboxylase 1 (Psd1) promotes mitochondrial fusion by regulating the biophysical properties of the mitochondrial membrane and alternative topogenesis of mitochondrial genome maintenance protein 1 (Mgm1). Journal of Biological Chemistry 287, 40131-40139, doi: 10.1074/jbc.M112.399428 (2012).
16. Mitsui, K., Nakagawa, D., Nakamura, M., Okamoto, T. & Tsurugi, K. Valproic acid induces apoptosis dependent of Yca1p at concentrations that mildly affect the proliferation of yeast. Febs Letters 579, 723-727, doi: 10.1016/j.febslet.2004.12.051 (2005).
17. Wilson, D. M. 3rd, Sofinowski, T. M. & McNeill, D. R. Repair mechanisms for oxidative DNA damage. Front Biosci 8, d963-d981 (2003).
18. Putnam, C. D., Jaehnig, E. J. & Kolodner, R. D. Perspectives on the DNA damage and replication checkpoint responses in Saccharomyces cerevisiae. DNA Repair 8, 974-982, doi: 10.1016/j.dnarep.2009.04.021 (2009).
19. Andreson, B. L., Gupta, A., Georgieva, B. P. & Rothstein, R. The ribonucleotide reductase inhibitor, Sml1, is sequentially phosphorylated, ubiquitylated and degraded in response to DNA damage. Nucleic Acids Res 38, 6490-6501, doi: 10.1093/nar/gkq552 (2010).
20. Sanvisens, N. et al. Yeast Dun1 kinase regulates ribonucleotide reductase inhibitor Sml1 in response to iron deficiency. Mol Cell Biol 34, 3259-3271, doi: 10.1128/MCB.00472-14 (2014).
21. Vaden, D. L., Ding, D., Peterson, B. & Greenberg, M. L. Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis. Journal of Biological Chemistry 276, 15466-15471, doi: 10.1074/jbc. M004179200 (2001).
22. Gonzalez, T. N., Sidrauski, C., Dorfler, S. & Walter, P. Mechanism of non-spliceosomal mRNA splicing in the unfolded protein response pathway. EMBO J 18, 3119-3132, doi: 10.1093/emboj/18.11.3119 (1999).
23. Jensen, A. N., Chindaudomsate, W., Thitiananpakorn, K., Mongkolsuk, S. & Jensen, L. T. Improper protein trafficking contributes to artemisinin sensitivity in cells lacking the KDAC Rpd3p. Febs Letters 588, 4018-4025, doi: 10.1016/j.febslet.2014.09.021 (2014).
24. Suresh, H. G. et al. Prolonged starvation drives reversible sequestration of lipid biosynthetic enzymes and organelle reorganization in Saccharomyces cerevisiae. Mol Biol Cell 26, 1601-1615, doi: 10.1091/mbc.E14-11-1559 (2015).
25. Gaspar, M. L., Hofbauer, H. F., Kohlwein, S. D. & Henry, S. A. Coordination of storage lipid synthesis and membrane biogenesis: evidence for cross-talk between triacylglycerol metabolism and phosphatidylinositol synthesis. Journal of Biological Chemistry 286, 1696-1708, doi: 10.1074/jbc.M110.172296 (2011).
26. Miyatake, M. et al. Valproic acid affects membrane trafficking and cell-wall integrity in fission yeast. Genetics 175, 1695-1705, doi: 10.1534/genetics.107.070946 (2007).
27. Levin, D. E. Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 69, 262-291, doi: 10.1128/ MMBR.69.2.262-291.2005 (2005).
28. Xie, N. et al. The role of p38 MAPK in valproic acid induced microglia apoptosis. Neurosci Lett 482, 51-56, doi: 10.1016/j. neulet.2010.07.004 (2010).
29. Gustin, M. C., Albertyn, J., Alexander, M. & Davenport, K. MAP kinase pathways in the yeast Saccharomyces cerevisiae. Microbiol Mol Biol Rev 62, 1264-1300 (1998).
30. Warmka, J., Hanneman, J., Lee, J., Amin, D. & Ota, I. Ptc1, a type 2C Ser/Thr phosphatase, inactivates the HOG pathway by dephosphorylating the mitogen-activated protein kinase Hog1. Mol Cell Biol 21, 51-60, doi: 10.1128/MCB.21.1.51-60.2001 (2001).
31. Gasch, A. P. In Yeast Stress Responses (eds Stefan, Hohmann & Willem H., Mager) 11-70 (Springer Berlin Heidelberg, 2003).
32. Hong, G., Zhang, W., Li, H., Shen, X. & Guo, Z. Separate enrichment analysis of pathways for up- and downregulated genes. J R Soc Interface 11, 20130950, doi: 10.1098/rsif.2013.0950 (2014).
33. Zhao, X. et al. The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells. Tumour Biol 32, 335-346, doi: 10.1007/s13277-010-0126-5 (2011).
34. Kiang, T. K. et al. Glutathione depletion by valproic acid in sandwich-cultured rat hepatocytes: Role of biotransformation and temporal relationship with onset of toxicity. Toxicol Appl Pharmacol 252, 318-324, doi: 10.1016/j.taap.2011.03.004 (2011).
35. Haynes, C. M., Titus, E. A. & Cooper, A. A. Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol Cell 15, 767-776, doi: 10.1016/j.molcel.2004.08.025 (2004).
36. Ounjaijean, S. et al. Increase in non-transferrin bound iron and the oxidative stress status in epilepsy patients treated using valproic acid monotherapy. Int J Clin Pharmacol Ther 49, 268-276, doi: 10.5414/CP201466 (2011).
37. Hayasaka, K. et al. Effects of valproate on biogenesis and function of liver mitochondria. Neurology 36, 351-356 (1986).
38. Chen, H., Dzitoyeva, S. & Manev, H. Effect of valproic acid on mitochondrial epigenetics. Eur J Pharmacol 690, 51-59, doi: 10.1016/j. ejphar.2012.06.019 (2012).
39. Sheftel, A., Stehling, O. & Lill, R. Iron-sulfur proteins in health and disease. Trends in endocrinology and metabolism: TEM 21, 302-314, doi: 10.1016/j.tem.2009.12.006 (2010).
40. Deranieh, R. M. et al. Perturbation of the Vacuolar ATPase: A NOVEL CONSEQUENCE OF INOSITOL DEPLETION. Journal of Biological Chemistry 290, 27460-27472, doi: 10.1074/jbc.M115.683706 (2015).
41. Zhang, L., Ma, N., Liu, Q. & Ma, Y. Genome-wide screening for genes associated with valproic acid sensitivity in fission yeast. Plos One 8, e68738, doi: 10.1371/journal.pone.0068738 (2013).
42. Lee, J. Y. et al. Valproic acid protects motor neuron death by inhibiting oxidative stress and endoplasmic reticulum stress-mediated cytochrome C release after spinal cord injury. J Neurotrauma 31, 582-594, doi: 10.1089/neu.2013.3146 (2014).
43. Almeida, B. et al. Drug-induced apoptosis in yeast. Biochim Biophys Acta 1783, 1436-1448, doi: 10.1016/j.bbamcr.2008.01.005 (2008).
44. Fagone, P. & Jackowski, S. Membrane phospholipid synthesis and endoplasmic reticulum function. J Lipid Res 50 Suppl, S311-S316, doi: 10.1194/jlr.R800049-JLR200 (2009).
45. Sun, Q., Bi, L., Su, X., Tsurugi, K. & Mitsui, K. Valproate induces apoptosis by inducing accumulation of neutral lipids which was prevented by disruption of the SIR2 gene in Saccharomyces cerevisiae. Febs Letters 581, 3991-3995, doi: 10.1016/j.febslet.2007.07.030 (2007).
46. Haghnazari, E. & Heyer, W. D. The DNA damage checkpoint pathways exert multiple controls on the efficiency and outcome of the repair of a double-stranded DNA gap. Nucleic Acids Res 32, 4257-4268, doi: 10.1093/nar/gkh717 (2004).
47. Sugiura, S. et al. Valproic Acid Increases Susceptibility to Endotoxin Shock through Enhanced Release of High-Mobility Group Box 1. Shock 36, 494-500, doi: 10.1097/SHK.0b013e31822f7e58 (2011).
48. O'Rourke, S. M., Herskowitz, I. & O'Shea, E. K. Yeast go the whole HOG for the hyperosmotic response. Trends Genet 18, 405-412 (2002).
49. Rodriguez-Pena, J. M., Garcia, R., Nombela, C. & Arroyo, J. The high-osmolarity glycerol (HOG) and cell wall integrity (CWI) signalling pathways interplay: a yeast dialogue between MAPK routes. Yeast 27, 495-502, doi: 10.1002/yea.1792 (2010).
50. Harrison, J. C., Zyla, T. R., Bardes, E. S. & Lew, D. J. Stress-specific activation mechanisms for the "cell integrity" MAPK pathway. Journal of Biological Chemistry 279, 2616-2622, doi: 10.1074/jbc.M306110200 (2004).
51. Golla, U., Joseph, D. & Tomar, R. S. In YEAST. S179-S180 (WILEY-BLACKWELL 111 RIVER ST, HOBOKEN 07030-5774 NJ, USA).
52. Poster Sessions. Yeast 32 Suppl 1, S93-S272, doi: 10.1002/yea.3092 (2015).
53. Azad, G. K. et al. Ebselen induces reactive oxygen species (ROS)-mediated cytotoxicity in Saccha-romyces cerevisiae with inhibition of glutamate dehydrogenase being a target. Febs Open Bio 4, 77-89, doi: 10.1016/j.fob.2014.01.002 (2014).
54. Azad, G. K., Singh, V., Golla, U. & Tomar, R. S. Depletion of Cellular Iron by Curcumin Leads to Alteration in Histone Acetylation and Degradation of Sml1p in Saccharomyces cerevisiae. Plos One 8, doi: ARTN e59003 10.1371/journal.pone.0059003 (2013).
55. Golla, U., Bandi, G. & Tomar, R. S. Molecular Cytotoxicity Mechanisms of Allyl Alcohol (Acrolein) in Budding Yeast. Chemical Research in Toxicology 28, 1246-1264, doi: 10.1021/acs.chemrestox.5b00071 (2015).
56. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 25, 402-408, doi: 10.1006/meth.2001.1262 (2001).
57. Golla, U. et al. Sen1p Contributes to Genomic Integrity by Regulating Expression of Ribonucleotide Reductase 1 (RNR1) in Saccharomyces cerevisiae. Plos One 8, doi: UNSP e64798 10.1371/journal.pone.0064798 (2013).
58. Guarente, L. Yeast promoters and lacZ fusions designed to study expression of cloned genes in yeast. Methods Enzymol 101, 181-191 (1983).
59. Miller, J. H. Experiments in molecular genetics (Cold Spring Harbor Laboratory, 1972).